Explore comprehensive CDMO services offered by CordenPharma, supporting end-to-end Anlaytical Testing, Drug Development, Manufacturing and Packaging. CordenPharma enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: France, Germany, Italy, Japan, Portugal, Spain, Switzerland, U.S.A.
Description: CordenPharma is a global pharmaceutical service and manufacturing company, or Contract Development and Manufacturing Organization (CDMO), owned by International Chemical Investors Group (ICIG). It provides full-service support for APIs, excipients, and drug products, with a strategic focus on five key technology platforms: Peptides, Lipids & Carbohydrates, Injectables, Highly Potent & Oncology, and Small Molecules.
